Cargando…

Effects of tocilizumab on mortality in hospitalized patients with COVID-19: a multicentre cohort study

OBJECTIVES: Tocilizumab has been proposed as a candidate therapy for patients with severe coronavirus disease 2019 (COVID-19), especially among those with higher systemic inflammation. We investigated the association between receipt of tocilizumab and mortality in a large cohort of hospitalized pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martínez-Sanz, Javier, Muriel, Alfonso, Ron, Raquel, Herrera, Sabina, Pérez-Molina, José A., Moreno, Santiago, Serrano-Villar, Sergio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510451/ https://www.ncbi.nlm.nih.gov/pubmed/32979572 http://dx.doi.org/10.1016/j.cmi.2020.09.021

Ejemplares similares

Weight changes after antiretroviral therapy initiation in CoRIS (Spain): a prospective multicentre cohort study
por: Martínez‐Sanz, Javier, et al.
Publicado: (2021)

HIV, Cancer, and the Microbiota: Common Pathways Influencing Different Diseases
por: Herrera, Sabina, et al.
Publicado: (2019)

Understanding clinical decision-making during the COVID-19 pandemic: A cross-sectional worldwide survey
por: Martínez-Sanz, Javier, et al.
Publicado: (2020)

Role of ACE2 genetic polymorphisms in susceptibility to SARS-CoV-2 among highly exposed but non infected healthcare workers
por: Martínez-Sanz, Javier, et al.
Publicado: (2021)

Similar CD4/CD8 Ratio Recovery After Initiation of Dolutegravir Plus Lamivudine Versus Dolutegravir or Bictegravir-Based Three-Drug Regimens in Naive Adults With HIV
por: Martínez-Sanz, Javier, et al.
Publicado: (2022)

Prevalence, characteristics, and associated risk factors of drug consumption and chemsex use among individuals attending an STI clinic (EpITs STUDY)
por: Rosas Cancio-Suárez, Marta, et al.
Publicado: (2023)

From Innovation to Implementation: The Evolution of HIV Pre-Exposure Prophylaxis and Future Implications
por: Rosas Cancio-Suárez, Marta, et al.
Publicado: (2023)

The microbiota as a modulator of mucosal inflammation and HIV/HPV pathogenesis: From association to causation
por: Moreno, Elena, et al.
Publicado: (2023)

Differential abundance of lipids and metabolites related to SARS-CoV-2 infection and susceptibility
por: Albóniga, Oihane E., et al.
Publicado: (2023)

Fecal microbiota transplantation in HIV: A pilot placebo-controlled study
por: Serrano-Villar, Sergio, et al.
Publicado: (2021)

Sustained remission of Multicentric Castleman Disease in children treated with tocilizumab
por: Galeotti, C, et al.
Publicado: (2011)

Implementation of a lung cancer screening initiative in HIV-infected subjects
por: Díaz-Álvarez, Jorge, et al.
Publicado: (2021)

Expanding HIV clinical monitoring: the role of CD4, CD8, and CD4/CD8 ratio in predicting non-AIDS events
por: Martínez-Sanz, Javier, et al.
Publicado: (2023)

Intravenous versus subcutaneous tocilizumab in Takayasu arteritis: multicentre retrospective study
por: Mekinian, Arsène, et al.
Publicado: (2023)

Beyond Undetectable Viral Load: Effect of Nucleotides on Inflammation
por: Moreno, Santiago, et al.
Publicado: (2016)

Response to Commentary: Long-term Changes of Inflammatory Biomarkers in Individuals on Suppressive Three-Drug or Two-Drug Antiretroviral Regimens
por: Serrano-Villar, Sergio, et al.
Publicado: (2022)

Matched cohort study on the efficacy of tocilizumab in patients with COVID-19
por: Rodríguez-Molinero, Alejandro, et al.
Publicado: (2021)

Lack of tocilizumab effect on mortality in COVID19 patients
por: Holt, Gregory E., et al.
Publicado: (2020)

Long-Term Changes of Inflammatory Biomarkers in Individuals on Suppressive Three-Drug or Two-Drug Antiretroviral Regimens
por: Serrano-Villar, Sergio, et al.
Publicado: (2022)

Idiopathic multicentric Castleman disease preceded by cutaneous plasmacytosis successfully treated by tocilizumab
por: Aita, Tetsuro, et al.
Publicado: (2020)

Psoas and Mediastinal Abscesses during Intravenous Tocilizumab Treatment in Multicentric Castleman Disease
por: Togitani, Kazuto, et al.
Publicado: (2022)

Correction: Intravenous versus subcutaneous tocilizumab in Takayasu arteritis: multicentre retrospective study
Publicado: (2023)

Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)
por: Rodríguez-Baño, Jesús, et al.
Publicado: (2021)

Differences in saliva ACE2 activity among infected and non-infected adult and pediatric population exposed to SARS-CoV-2
por: Jiménez, Daniel, et al.
Publicado: (2022)

Relationship of Diet to Gut Microbiota and Inflammatory Biomarkers in People with HIV
por: Manzano, Mónica, et al.
Publicado: (2022)

Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study
por: Blanco, Jesús, et al.
Publicado: (2008)

Treatment of multicentric Castleman disease through combination of tocilizumab, lenalidomide and glucocorticoids: Case report
por: Cai, Sisi, et al.
Publicado: (2019)

Experience with tocilizumab in severe COVID-19 pneumonia after 80 days of follow-up: A retrospective cohort study
por: Moreno-Pérez, Oscar, et al.
Publicado: (2020)

Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort Study
por: Ruiz-Antorán, Belén, et al.
Publicado: (2020)

Impact of tocilizumab administration on mortality in severe COVID-19
por: Tsai, Andrew, et al.
Publicado: (2020)

Predictors of Mortality in Tocilizumab-Treated Severe COVID-19
por: Pagkratis, Konstantinos, et al.
Publicado: (2022)

Impact of the Addition of Baricitinib to Standard of Care Including Tocilizumab and Corticosteroids on Mortality and Safety in Severe COVID-19
por: Masiá, Mar, et al.
Publicado: (2021)

Idiopathic multicentric Castleman disease with pulmonary and cutaneous lesions treated with tocilizumab: A case report
por: Han, Ping-Yang, et al.
Publicado: (2020)

Tocilizumab among patients with COVID-19 in the intensive care unit: a multicentre observational study
por: Biran, Noa, et al.
Publicado: (2020)

Aseptic Meningitis-retention Syndrome Associated with Tocilizumab in a Patient with Idiopathic Multicentric Castleman Disease
por: Arakawa, Akira, et al.
Publicado: (2021)

Use of tocilizumab in COVID-19 pneumonia hospitalized patients. Cohort study
por: Anci, Cynthia, et al.
Publicado: (2023)

Impact of tocilizumab on mortality and/or invasive mechanical ventilation requirement in a cohort of 206 COVID-19 patients
por: Klopfenstein, Timothée, et al.
Publicado: (2020)

Predictive value of CD8+ T cell and CD4/CD8 ratio at two years of successful ART in the risk of AIDS and non-AIDS events
por: Serrano-Villar, Sergio, et al.
Publicado: (2022)

Idiopathic Multicentric Castleman Disease with Autoimmune Hemolytic Anemia and Production of Anti-drug Antibody against Tocilizumab
por: Tabata, Sakiko, et al.
Publicado: (2019)

Screening for precancerous anal lesions with P16/Ki67 immunostaining in HIV-infected MSM
por: Serrano-Villar, Sergio, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_tg6v4ae5o4g8imtldqtshrs7ab